O'Bryan R - Search Results

1

Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.

Bukowski RM, Legha S, Saiki J, Eyre HJ, O'Bryan R. Bukowski RM, et al. Cancer Treat Rep. 1982 Aug;66(8):1651-2. Cancer Treat Rep. 1982. PMID: 6286120

2

Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.

Inamasu M, Oishi N, Chen T, Legha S, McCracken J, Balcerzak S, Stephens R, O'Bryan R, Rivkin SE, Costanzi JJ, et al. Inamasu M, et al. Cancer Treat Rep. 1984 Nov;68(11):1411-2. Cancer Treat Rep. 1984. PMID: 6548661 No abstract available.

3

Phase II study of 5-azacytidine in solid tumors.

Quagliana JM, O'Bryan RM, Baker L, Gottlieb J, Morrison FS, Eyre HJ, Tucker WG, Costanzi J. Quagliana JM, et al. Cancer Treat Rep. 1977 Jan-Feb;61(1):51-4. Cancer Treat Rep. 1977. PMID: 67893

4

Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.

Taylor SA, McCracken JD, Eyre HJ, O'Bryan RM, Neilan BA. Taylor SA, et al. J Neurooncol. 1985;3(2):131-5. doi: 10.1007/BF02228889. J Neurooncol. 1985. PMID: 2993536

5

Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

Oishi N, Berenberg J, Blumenstein BA, Johnson K, Rivkin SE, Bukowski RM, O'Bryan RM, Stephens RL, Quagliana J, Saiers JH, et al. Oishi N, et al. Cancer Treat Rep. 1987 Dec;71(12):1307-8. Cancer Treat Rep. 1987. PMID: 3690547 No abstract available.

6

High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.

Stephens RL, Kirby R, Crawford ED, Bukowski R, Rivkin SE, O'Bryan RM. Stephens RL, et al. Invest New Drugs. 1986;4(1):57-9. doi: 10.1007/BF00172018. Invest New Drugs. 1986. PMID: 3700042

7

Bisantrene hydrochloride in gastric adenocarcinoma: a Southwest Oncology Group Study.

Panettiere FJ, Jones SE, Oishi N, Eyre HJ, O'Bryan RM, Andes WA, Taylor SA, Grozea PN. Panettiere FJ, et al. Med Pediatr Oncol. 1986;14(2):78-80. doi: 10.1002/mpo.2950140204. Med Pediatr Oncol. 1986. PMID: 3713640

8

Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.

Bukowski RM, Balcerzak SP, O'Bryan RM, Bonnet JD, Chen TT. Bukowski RM, et al. Cancer. 1983 Nov 1;52(9):1577-82. doi: 10.1002/1097-0142(19831101)52:9<1577::aid-cncr2820520906>3.0.co;2-8. Cancer. 1983. PMID: 6225508 Clinical Trial.

9

Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.

Costanzi JJ, Fletcher WS, Balcerzak SP, Taylor S, Eyre HJ, O'Bryan RM, Al-Sarraf M, Frank J. Costanzi JJ, et al. Cancer. 1984 Feb 15;53(4):833-6. doi: 10.1002/1097-0142(19840215)53:4<833::aid-cncr2820530402>3.0.co;2-#. Cancer. 1984. PMID: 6362830 Clinical Trial.

10

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study.

Budd GT, Fleming TR, Bukowski RM, McCracken JD, Rivkin SE, O'Bryan RM, Balcerzak SP, Macdonald JS. Budd GT, et al. J Clin Oncol. 1987 Feb;5(2):272-7. doi: 10.1200/JCO.1987.5.2.272. J Clin Oncol. 1987. PMID: 3543246 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters